LEDY OCHOA: Open Payments
NPI 1740609072 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,362 in 129 payments from 13 companies in 2025. Trend: 2023 $1,220 · 2024 $1,170 · 2025 $3,362
Food & beverage: $3,263Education: $99
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $582 |
| Regeneron Healthcare Solutions, Inc. | 19 | $521 |
| GENZYME CORPORATION | 13 | $457 |
| Arcutis Biotherapeutics, Inc. | 10 | $389 |
| Incyte Corporation | 13 | $335 |
| ABBVIE INC. | 11 | $256 |
| PFIZER INC. | 16 | $256 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $198 |
| Lilly USA, LLC | 3 | $155 |
| UCB, Inc. | 4 | $142 |
Products named: DUPIXENT, NEMLUVIO, Zoryve, OPZELURA, RINVOQ, CIBINQO, Winlevi, Bimzelx.
Industry payments across FL — which companies pay providers there.
